BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20104581)

  • 1. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
    Koledova Z; Kafkova LR; Krämer A; Divoky V
    Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
    Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
    Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cells are capable of executing G1/S checkpoint activation.
    Bárta T; Vinarský V; Holubcová Z; Dolezalová D; Verner J; Pospísilová S; Dvorák P; Hampl A
    Stem Cells; 2010 Jul; 28(7):1143-52. PubMed ID: 20518019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
    Jin J; Ang XL; Ye X; Livingstone M; Harper JW
    J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
    Agner J; Falck J; Lukas J; Bartek J
    Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
    Sampath D; Shi Z; Plunkett W
    Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells.
    Koledova Z; Kafkova LR; Calabkova L; Krystof V; Dolezel P; Divoky V
    Stem Cells Dev; 2010 Feb; 19(2):181-94. PubMed ID: 19737069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.
    Hassepass I; Voit R; Hoffmann I
    J Biol Chem; 2003 Aug; 278(32):29824-9. PubMed ID: 12759351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
    Fukasawa T; Enomoto A; Miyagawa K
    Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid destruction of human Cdc25A in response to DNA damage.
    Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
    Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.
    van der Laan S; Tsanov N; Crozet C; Maiorano D
    Mol Cell; 2013 Nov; 52(3):366-79. PubMed ID: 24207026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.
    Hong Y; Stambrook PJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14443-8. PubMed ID: 15452351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
    Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
    Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
    Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
    Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
    Zhao H; Watkins JL; Piwnica-Worms H
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
    Uto K; Inoue D; Shimuta K; Nakajo N; Sagata N
    EMBO J; 2004 Aug; 23(16):3386-96. PubMed ID: 15272308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2.
    Bourke E; Brown JA; Takeda S; Hochegger H; Morrison CG
    Oncogene; 2010 Jan; 29(4):616-24. PubMed ID: 19838212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.